Moderna COVID-19 Vaccine Nearly 95% Effective, Shows Data | COVID Update

Sunday, 24 January 2021

daily news

Moderna COVID-19 Vaccine Nearly 95% Effective, Shows Data

G Plus News | November 16, 2020 18:16 hrs

A new vaccine that protects against COVID-19 is nearly 95% effective, early data from US company Moderna shows.

Moderna Inc, one of the leading companies in the COVID-19 vaccine has claimed "95% effectiveness of its new vaccine."

As reported by Reuters, the company says its experimental vaccine is 94.5% effective in preventing the COVID-19 based on interim data from a late-stage clinical trial.

An interim analysis released on Mon
day, and based on 95 patients with confirmed Covid infections, found the candidate vaccine has an efficacy of 94.5%. The company said it now plans to apply to the US regulator, the Food and Drug Administration, for emergency-use authorisation in the coming weeks. In the analysis, 90 of the patients received the placebo with the remaining five the vaccine.

Moderna says it is a "great day" and they plan to apply for approval to use the vaccine in the next few weeks.

However, this is still early data and key questions remain unanswered.

Comments (0) Post Comment